C
Therapeutic Areas
Shield Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Accrufer (ferric maltol) | Iron Deficiency Anemia (IDA) in adults | Commercial |
| Feraccru (ferric maltol) | Iron Deficiency Anemia (IDA) in adults | Commercial |
| Ferric Maltol | IDA in patients with Inflammatory Bowel Disease (IBD) | Phase 3 |